Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2609-2614

  Dudiuk, Catiana ^a,b   Gamarra, Soledad ^a   Leonardeli, Florencia ^a   Jimenez Ortigosa, Cristina ^c   Vitale, Roxana G ^b,d   Afeltra, Javier ^d,e   Perlin, David S ^c   Garcia Effron, Guillermo ^a,b  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d HOSPITAL RAMOS MEJÍA   (Argentina)

^e UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINOCANDIN; ANTIFUNGAL AGENT; FUNGAL PROTEIN; GLUCOSYLTRANSFERASE; MUTANT PROTEIN;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA GLABRATA; CONTROLLED STUDY; DNA SEQUENCE; FKS GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; AMINO ACID SUBSTITUTION; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; PROCEDURES; UNITED STATES;

AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGAL PROTEINS; GLUCOSYLTRANSFERASES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTANT PROTEINS; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84903785055     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01038-14     Document Type: Article

References (35)

1. Axner-Elings M, Botero-Kleiven S, Jensen RH, Arendrup MC. 2011. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. J. Clin. Microbiol. 49:2516-2521. http://dx.doi.org/10. 1128/JCM.00201-11.
2. Guinea J. 10 February 2014. Global trends in the distribution of Candida species causing candidemia. Clin. Microbiol. Infect. http://dx.doi.org/10.1111/ 1469-0691.12539.
3. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48:1695-1703. http://dx.doi.org/10.1086/ 599039.
4. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D. 2012. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagn. Microbiol. Infect. Dis. 74:323-331. http://dx.doi.org/10.1016/j. diagmicrobio.2012.10.003.
5. Rodriguez-Tudela JL, Gomez-Lopez A, Arendrup MC, Garcia-Effron G, Perlin DS, Lass-Florl C, Cuenca-Estrella M. 2010. Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose. Antimicrob. Agents Chemother. 54:3056-3057. http://dx.doi.org/10.1128/AAC.00597- 10.
6. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. 2011. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob. Agents Chemother. 55:532-538. http://dx.doi.org/10.1128/ AAC.01128-10.
7. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin. Infect. Dis. 56:1724-1732. http://dx.doi.org/10.1093/cid/cit136.
8. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O. 2012. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg. Infect. Dis. 18:86-90. http://dx.doi.org/10.3201/eid1801.110556.
9. Liu W, Tan J, Sun J, Xu Z, Li M, Yang Q, Shao H, Zhang L, Liu W, Wan Z, Cui W, Zang B, Jiang D, Fang Q, Qin B, Qin T, Li W, Guo F, Liu D, Guan X, Yu K, Qiu H, Li R. 2014. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study. J. Antimicrob. Chemother. 69:162-167. http://dx.doi.org/10.1093/jac/dkt330.
10. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. 2012. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J. Clin. Microbiol. 50:1199-1203. http://dx.doi.org/10.1128/JCM.06112-11.
11. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Document M27-A3. CLSI, Wayne, PA.
12. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2012. Method for the determination of broth dilution minimum Inhibitory concentrations of antifungal agents for yeasts. EUCAST definitive document EDef 7.2 revision. EUCAST, Växjö, Sweden.
13. Clinical and Laboratory Standards Institute. 2012. Reference method for broth dilution antifungal susceptibility testing of yeast-4th informational supplement-CLSI document M27-S4. CLSI, Wayne, PA.
14. Arendrup MC, Garcia-Effron G, Lass-Florl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob. Agents Chemother. 54:426-439. http://dx.doi.org/10.1128/AAC.01256- 09.
15. Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS. 2008. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob. Agents Chemother. 52:2263-2265. http://dx.doi.org/10.1128/AAC.01568-07. (Pubitemid 351758575)
16. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699. http://dx.doi.org/10.1128/AAC.00443-09.
17. Katiyar S, Pfaller M, Edlind T. 2006. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob. Agents Chemother. 50:2892-2894. http://dx.doi.org/10.1128/AAC.00349- 06. (Pubitemid 44198725)
18. Perlin DS. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10:121-130. http://dx.doi.org/10.1016/j.drup.2007.04.002. (Pubitemid 47031054)
19. Pham CD, Bolden CB, Kuykendall RJ, Lockhart SR. 2014. Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata. J. Clin. Microbiol. 52: 790-795. http://dx.doi.org/10.1128/JCM.03378-13.
20. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. http://dx.doi.org/10.1086/323335. (Pubitemid 33152659)
21. Kurzman CP, Fell JW, Boekhout T. 2011. The yeast-a taxonomic study. Elsevier, London, United Kingdom.
22. White TJ, Bruns TD, Lee SB, Taylor JW. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p 315-322. Innis MA, Gelfand DH, Sninsky JJ, White TJ (ed), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, CA.
23. Sambrook J, Fritsch EF, Maniatis T. 1998. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. 2010. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob. Agents Chemother. 54:5042-5047. http://dx.doi.org/10.1128/AAC.00836-10.
25. Morrell M, Fraser VJ, Kollef MH. 2005. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645. http://dx.doi.org/10.1128/AAC.49.9.3640-3645.2005. (Pubitemid 41233011)
26. Bizerra FC, Jimenez-Ortigosa C, Souza AC, Breda Queiroz-Telles F, Perlin DS, Colombo AL. 2014. Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin. Antimicrob. Agents Chemother. 58:2438-2440. http://dx.doi.org/10.1128/AAC.02189-13.
27. Castanheira M, Woosley LN, Diekema DJ, Messer SA, Jones RN, Pfaller MA. 2010. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrob. Agents Chemother. 54:2655-2659. http://dx.doi.org/10.1128/AAC.01711-09.
28. Garcia-Effron G, Chua DJ, Tomada JR, Dipersio J, Perlin DS, Ghannoum M, Bonilla H. 2010. Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrob. Agents Chemother. 54: 2225-2227. http://dx.doi.org/10.1128/AAC.00998-09.
29. Katiyar SK, Alastruey-Izquierdo A, Healey KR, Johnson ME, Perlin DS, Edlind TD. 2012. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance. Antimicrob. Agents Chemother. 56:6304-6309. http://dx.doi.org/10.1128/AAC.00813- 12.
30. Messer SA, Jones RN, Moet GJ, Kirby JT, Castanheira M. 2010. Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008). J. Clin. Microbiol. 48:2984-2987. http://dx.doi.org/10.1128/JCM.00328-10.
31. Thompson GR III, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS, Patterson TF. 2008. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob. Agents Chemother. 52:3783-3785. http://dx.doi.org/10.1128/AAC.00473- 08.
32. Balashov SV, Park S, Perlin DS. 2006. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob. Agents Chemother. 50:2058-2063. http://dx.doi.org/10.1128/AAC.01653-05. (Pubitemid 43807526)
33. Garcia-Effron G, Dilger A, Alcazar-Fuoli L, Park A, Mellado E, Perlin DS. 2008. Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J. Clin. Microbiol. 46:1200-1206. http://dx.doi.org/10.1128/JCM. 02330-07. (Pubitemid 351563556)
34. Perlin DS, Balashov S, Park S. 2008. Multiplex detection of mutations. Methods Mol. Biol. 429:23-31. http://dx.doi.org/10.1007/978-1-60327-040-3-2.
35. Quindos G. 2014. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev. Iberoam. Micol. 31:42-48. http://dx.doi.org/10.1016/j.riam. 2013.10.001.